Literature DB >> 9734957

Juvenile chronic arthritis.

P Woo1, L R Wedderburn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9734957

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  23 in total

Review 1.  [Malignancy and tumor necrosis factor inhibitors in juvenile idiopathic arthritis].

Authors:  G Horneff
Journal:  Z Rheumatol       Date:  2010-08       Impact factor: 1.372

2.  Comparison between Children with Juvenile Idiopathic Arthritis (JIA) and their parents concerning perceived Quality of Life.

Authors:  Karine Toupin April; Debbie Ehrmann Feldman; Robert W Platt; Ciarán M Duffy
Journal:  Qual Life Res       Date:  2006-05       Impact factor: 4.147

3.  Role of basophils in rheumatoid arthritis (Review).

Authors:  Pei Tang; Qiuhua Chen; Qiaofen Lan; Yanwen Chen; Haijuan Yang; Ning An; Haiyan Xiao; Huafeng Liu; Ping Wu; Tong Xie; Qingjun Pan
Journal:  Exp Ther Med       Date:  2015-02-24       Impact factor: 2.447

Review 4.  Etanercept: an updated review of its use in rheumatoid arthritis, psoriatic arthritis and juvenile rheumatoid arthritis.

Authors:  Christine R Culy; Gillian M Keating
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 5.  Heat shock proteins in juvenile idiopathic arthritis: keys for understanding remitting arthritis and candidate antigens for immune therapy.

Authors:  Berent Prakken; Wietse Kuis; Willem van Eden; Salvatore Albani
Journal:  Curr Rheumatol Rep       Date:  2002-12       Impact factor: 4.592

6.  Improvement of functional ability in children with juvenile idiopathic arthritis by treatment with etanercept.

Authors:  M Halbig; G Horneff
Journal:  Rheumatol Int       Date:  2009-12       Impact factor: 2.631

Review 7.  The German etanercept registry for treatment of juvenile idiopathic arthritis.

Authors:  G Horneff; H Schmeling; T Biedermann; I Foeldvari; G Ganser; H J Girschick; T Hospach; H I Huppertz; R Keitzer; R M Küster; H Michels; D Moebius; B Rogalski; A Thon
Journal:  Ann Rheum Dis       Date:  2004-04-28       Impact factor: 19.103

8.  Prevalence and clinical significance of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis.

Authors:  T Avcin; R Cimaz; F Falcini; F Zulian; G Martini; G Simonini; V Porenta-Besic; G Cecchini; M O Borghi; P L Meroni
Journal:  Ann Rheum Dis       Date:  2002-07       Impact factor: 19.103

9.  S100A12 is a novel molecular marker differentiating systemic-onset juvenile idiopathic arthritis from other causes of fever of unknown origin.

Authors:  Helmut Wittkowski; Michael Frosch; Nico Wulffraat; Raphaela Goldbach-Mansky; Tilmann Kallinich; Jasmin Kuemmerle-Deschner; Michael C Frühwald; Sandra Dassmann; Tuyet-Hang Pham; Johannes Roth; Dirk Foell
Journal:  Arthritis Rheum       Date:  2008-12

10.  Association between perceived treatment adherence and health-related quality of life in children with juvenile idiopathic arthritis: perspectives of both parents and children.

Authors:  Karine Toupin April; Debbie Ehrmann Feldman; Maria Victoria Zunzunegui; Ciarán M Duffy
Journal:  Patient Prefer Adherence       Date:  2008-02-02       Impact factor: 2.711
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.